The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza.
대표청구항▼
1. A method of treating a subject, the method comprising steps of: administering to a subject suffering from or susceptible to influenza infection a therapeutically effective amount of an antibody that comprises a heavy chain having an amino acid sequence that is at least 95% identical to SEQ ID NO:
1. A method of treating a subject, the method comprising steps of: administering to a subject suffering from or susceptible to influenza infection a therapeutically effective amount of an antibody that comprises a heavy chain having an amino acid sequence that is at least 95% identical to SEQ ID NO:1 and a light chain having an amino acid sequence that is at least 95% identical to one of SEQ ID NOs:33-43. 2. The method of claim 1, wherein the antibody is formulated for administration by a route selected from the group consisting of oral, intravenous, intramuscular, intra-arterial, subcutaneous, intraventricular, transdermal, interdermal, rectal, intravaginal, intraperitoneal, topical, mucosal, nasal, buccal, enteral, sublingual, intratracheal or bronchial. 3. The method of claim 2, wherein the administration is by intratracheal or bronchial instillation. 4. The method of claim 2, wherein the administration is by inhalation. 5. The method of claim 1, wherein the antibody is formulated as an oral spray, a nasal spray, or an aerosol. 6. A method of detecting a hemagglutinin (HA) polypeptide in a sample, the method comprising steps of: contacting a sample with an antibody that comprises a heavy chain having an amino acid sequence that is at least 95% identical to SEQ ID NO:1 and a light chain having an amino acid sequence that is at least 95% identical to one of SEQ ID NO:33-43; anddetecting binding in the sample. 7. The method of claim 6, wherein the sample is or comprises one or more of blood, serum/plasma, peripheral blood mononuclear cells/peripheral blood lymphocytes (PBMC/PBL), sputum, urine, feces, throat swabs, dermal lesion swabs, cerebrospinal fluids, cervical smears, pus samples, food matrices, and tissues from various parts of the body such as brain, spleen, and liver. 8. The method of 6, wherein the sample is an environmental sample. 9. The method of claim 8, wherein the environmental sample is or comprises one or more of soil, water and flora.
Hubbard Vance M. (Bedford) Brunson Welton K. (Bedford) Saied V. C. (Wichita Falls TX), Apparatus and method for raising a skin wheal and anesthetizing skin.
Lilley Stephen J. (Sawston GBX) Taylor Hugh F. (Sawston GBX) Theobald David R. (Huntingdon GBX) Carlson Craig J. (Andover MA) Rosen David I. (Arlington MA) Johnson Thomas R. (Milford NH), Medical injection system and method, gas spring thereof and launching device using gas spring.
Gansow Otto A. (3003 Van Ness ; NW. ; W 524 Washington DC 20008) Strand Mette (807 Harper House ; Village of Cross Keys Baltimore MD 21210), Metal chelate conjugated monoclonal antibodies.
Ring David B. (Redwood City CA) Frankel Arthur E. (Durham NC), Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Cabilly Shmuel (Monrovia CA) Heyneker Herbert L. (Burlingame CA) Holmes William E. (Pacifica CA) Riggs Arthur D. (La Verne CA) Wetzel Ronald B. (San Francisco CA), Recombinant immunoglobin preparations.
Deboer Herman A.,NLX ; Strijker Rein,NLX ; Heyneker Herbert L. ; Platenburg Gerard,NLX ; Lee Sang He,NLX ; Pieper Frank,NLX ; Krimpenfort Paul J. A.,NLX, Transgenic bovine.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.